US pharmacy chain Walgreens Boots Alliance said it had reduced its stake in pharmaceutical distributor Cencora, for the third time in just over six months, generating about $992m in proceeds. The revenue includes about $942 million from shares sold, as well as about $50 million from a simultaneous share repurchase by Cencora (formerly AmerisourceBergen).